Managers / Q4 2018 · view latest →
ROSENBLUM SILVERMAN SUTTON S F INC /CA
CIK 0000918893 · 1388 SUTTER STREET, SUITE 725, SAN FRANCISCO, CA, 94109 · 4157713618
Summary
Rosenblum Silverman Sutton S F Inc /Ca reported $219M in U.S.-listed holdings across 59 positions for Q4 2018.
Its largest position, AMZN, represents 6.4% of the portfolio.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 82.7% · $181M
- Other · 12.9% · $28M
- ADR · 2.9% · $6M
- REIT · 1.4% · $3M
Quarter-over-Quarter Changes full breakdown →
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| AMZNAmazon.Com, Inc | NEW | +9.4K | 9.4K | +$14M | $14M |
| URIVisa Inc. | NEW | +101.4K | 101.4K | +$13M | $13M |
| ILMNIllumina Inc. | NEW | +40.1K | 40.1K | +$12M | $12M |
| ADBEAdobe Systems | NEW | +48.0K | 48.0K | +$11M | $11M |
| Facebook Inc. Class A | NEW | +70.9K | 70.9K | +$9M | $9M |
| DWDNetflix Inc. | NEW | +31.7K | 31.7K | +$8M | $8M |
| Thermo Fisher Scientific | NEW | +37.4K | 37.4K | +$8M | $8M |
| MRKMicrosoft | NEW | +82.4K | 82.4K | +$8M | $8M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2018
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $382M | 76 | May 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $432M | 80 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $438M | 78 | Nov 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $413M | 77 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $363M | 75 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $398M | 74 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $391M | 77 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $373M | 75 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $353M | 74 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $314M | 73 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $294M | 71 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $303M | 69 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | Under review | 62 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 64 | Feb 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $277M | 73 | Nov 15, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2022 | $308M | 73 | Aug 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $391M | 71 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $444M | 70 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $437M | 70 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $444M | 70 | Aug 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $390M | 70 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $384M | 69 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $356M | 64 | Nov 9, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $312M | 60 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $250M | 68 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $274M | 55 | Jan 24, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $260M | 57 | Nov 1, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $264M | 57 | Jul 31, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $252M | 55 | Apr 25, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $219M | 59 | Feb 6, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.